PHASEBIO PHARMACEUTICALS INC's ticker is PHAS and the CUSIP is 717224109. A total of 61 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | -100.0% | 3,317 | +257.8% | 0.00% | – |
| Q1 2022 | $1,000 | -96.7% | 927 | -92.1% | 0.00% | – |
| Q4 2021 | $30,000 | +2900.0% | 11,725 | +2711.8% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 417 | -19.3% | 0.00% | – |
| Q2 2021 | $1,000 | -95.5% | 517 | -92.3% | 0.00% | – |
| Q4 2020 | $22,000 | +69.2% | 6,744 | +137.5% | 0.00% | – |
| Q2 2020 | $13,000 | – | 2,839 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|